SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001225208-12-019561
Filing Date
2012-09-13
Accepted
2012-09-13 16:34:17
Documents
1
Period of Report
2012-08-15

Document Format Files

Seq Description Document Type Size
1 doc4.html 4  
1 doc4.xml 4 4148
  Complete submission text file 0001225208-12-019561.txt   5581
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 425 METRO PLACE N., SUITE 300 DUBLIN OH 43017
Business Address
Troup Gordon A (Reporting) CIK: 0001441122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 121090480